Miller Steve

Chief Op. & Scientific OfficerCATALYST PHARMACEUTICALS, INC. (CPRX) · full profile →Form 4 · filed Aug 28, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.3M
Net Open-Market Flow
-$2.3M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2025Option exercise(M)110K$2.24$246K1.1M
Aug 26, 2025Option exercise(M)115K$2.24$258K1.1M
Aug 26, 2025Sell(S)115K$20.28$2.3M950K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 27, 2025Option exercise(M)110K$01.3M
Aug 26, 2025Option exercise(M)115K$01.4M

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001161697-25-000301) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.